SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-014759
Filing Date
2020-06-12
Accepted
2020-06-12 08:03:48
Documents
96
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2019_biondvaxpharma.htm 20-F 2067820
2 ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD f20f2019ex1-1_biondvax.htm EX-1.1 321128
3 DESCRIPTION OF SHARE CAPITAL f20f2019ex2-3_biondvax.htm EX-2.3 138887
4 2005 SHARE INCENTIVE PLAN f20f2019ex4-1_biondvax.htm EX-4.1 99769
5 2018 SHARE INCENTIVE PLAN f20f2019ex4-2_biondvax.htm EX-4.2 115611
6 REMUNERATION POLICY f20f2019ex4-3_biondvax.htm EX-4.3 122654
7 CERTIFICATION f20f2019ex12-1_biondvax.htm EX-12.1 9453
8 CERTIFICATION f20f2019ex12-2_biondvax.htm EX-12.2 9598
9 CERTIFICATION f20f2019ex13-1_biondvax.htm EX-13.1 3483
10 CERTIFICATION f20f2019ex13-2_biondvax.htm EX-13.2 3467
11 GRAPHIC fin_001.jpg GRAPHIC 6951
12 GRAPHIC img_001.jpg GRAPHIC 33982
13 GRAPHIC ex4-3_001.jpg GRAPHIC 13952
  Complete submission text file 0001213900-20-014759.txt   8445135

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE bvxv-20191231.xml EX-101.INS 1502626
15 XBRL SCHEMA FILE bvxv-20191231.xsd EX-101.SCH 91080
16 XBRL CALCULATION FILE bvxv-20191231_cal.xml EX-101.CAL 56697
17 XBRL DEFINITION FILE bvxv-20191231_def.xml EX-101.DEF 279131
18 XBRL LABEL FILE bvxv-20191231_lab.xml EX-101.LAB 436718
19 XBRL PRESENTATION FILE bvxv-20191231_pre.xml EX-101.PRE 343072
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 20958908
SIC: 2836 Biological Products, (No Diagnostic Substances)